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A simple and reliable assay for interleukin-1 (IL-1) is described which has the advantage over other 
assays that it is independent of interleukin-2 (IL-2) production by the test cells. The assay makes possible 
the detection of IL-1 in the supernatants of T cell populations. The ability of IL-1 to induce IL-2 receptor 
expression in the absence of T cell mitogen is the basis of this assay. Thus, proliferation of mouse 
thymocytes incubated in the presence of saturating concentrations of IL-2 (10 U/ml)  was directly 
dependent on the concentration of IL-1. The sensitivity of the assay is comparable to the sensitivity of the 
classical thymocyte co-stimulator assay. Natural and recombinant human and murine IL-1 were measured 
in this test system with comparable sensitivity. 
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Introduction 
The term interleukin-1 (IL-1) represents a group 
of low molecular weight proteins which are pro- 
duced by a variety of cells and have a wide range 
of biological activities (Dinarello, 1985). The best 
known IL-1 producer cells are monocytes/macro- 
phages, B cells (Scala et al., 1984) and epidermal 
cells (Luger et al., 1985). Production of IL-1 by 
cells of the T cell lineage has also been reported 
(Tartakovsky et al., 1986). The most widely used 
assays for IL-1 activity are the lymphocyte-activat- 
ing factor (LAF) assay (Gery et al., 1972) and the 
thymocyte co-stimulator assay (Shaw et al., 1978). 
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Two other assay systems use T cell lymphomas 
which are inducible by IL-1 plus mitogen or the 
Ca ionophore A23187 (Conlon, 1983; Simon et al., 
1985) to produce IL-2. This IL-2 activity is then 
measured with an IL-2-dependent cell line. 
Another assay was described by Kaye et al. (1983). 
In this assay growth of the T cell hybridoma 
D10.G4.1 is stimulated by IL-1 plus a monoclonal 
antibody to the T cell antigen receptor. All these 
assays measure IL-1 more or less indirectly through 
IL-2 production. Therefore, samples which al- 
ready contain IL-2-1ike activities - like most su- 
pernatants of T cell-containing cultures - cannot 
be tested for their IL-1 content. In a recent pub- 
lication (Mannel et al., 1985) we have described 
another function of IL-1 in T cell activation, 
namely the induction of IL-2 receptor expression. 
Thus, in the standard co-stimulator assay two 
effects of IL-1, the induction of IL-2 receptors 
and IL-2 production (resulting in proliferation) 
are being measured. We have used this finding to 
devise a simple and reliable assay system for IL-1 
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which measures only one effect of IL-1 (the induc- 
tion of IL-2 receptor expression) and is therefore 
independent of endogenously produced IL-2. 
Materials and methods 
Mice 
Male C3H/He J  mice were purchased 
Jackson Laboratories, Bar Harbour, ME. 
animals were used at 4-10 weeks of age. 
from 
The 
Culture medium 
The culture medium used was RPMI 1640 
(Gibco) with L-glutamine (2 × 10 -3 M) and sup- 
plemented with 10% heat-inactivated fetal calf 
serum, 2-mercaptoethanol  (3 × 10-s  M), 
gentamycin (50/lg/ml),  and Hepes (0.02 M). 
Reagents 
Phytohemagglutinin (PHA)-P and PHA-M were 
obtained from Sigma, [6- 3H]thymidine (3 H-TdR) 
was purchased from Amersham and had a specific 
activity of 50 Ci /mmol (185 GBq/mmol).  
Preparation of purified human IL-1 
The protocol described by Kronheim et al. 
(1985) was used with a minor modification. Briefly, 
peripheral lymphocytes were obtained from 
healthy individuals undergoing leukapheresis. The 
cell suspension was diluted with phosphate- 
buffered saline and separated on a Ficoll cushion 
(B6yum, 1962). The interphase layer containing 
the mononuclear cells was washed four times with 
culture medium. Centrifugations were performed 
at 200 x g. The cells were cultured in medium 
with 0.01% fetal calf serum and 0.01 mg/ml  
glutaraldehyde-fixed Staphylococcus aureus cells 
(Pansorbin, Calbiochem) in large petri dishes (177 
cm 2) at a density of 2 x 106/ml. Incubation was 
done for 24 h at 37°C in 5% CO 2 and at 90% 
relative humidity. Sodium azide (0.02%) was ad- 
ded to the cell-free supernatants. The supernatants 
were stored at 4°C. The supernatants were ad- 
justed to 10 mM citrate and the pH was titrated to 
4 with 20% hydrochloric acid. The material was 
applied to an SP-Sephadex (Pharmacia) column 
and the column was washed with 4 vols. of 10 mM 
citrate pH 4, 150 mM sodium chloride. A second 
wash was performed with four column volumes of 
10 mM 2-(N-morpholino)ethane sulphuric acid 
(MES) buffer pH 5. Elution from the column was 
performed with 10 mM Tris-HC1 pH 8.5. IL-1 
activity eluted with the rise in pH. The active 
fractions were pooled. This pool was applied to a 
mono-Q-column (FPLC apparatus, Pharmacia) 
which was equilibrated in 10 mM Tris pH 8.5. 
After application, the column was washed with 10 
ml of starting buffer and then a sodium chloride 
gradient in 10 mM Tris from 0 to 0.4 M was 
applied. IL-1 activity eluted in the first fractions 
with a peak of activity at a molarity of 0.05 M. 
These fractions were pooled and stored at 4 °C. 
Further purification was not considered necessary 
for our purposes. 
Preparation of purified mouse IL-1 
IL-1 was prepared from P388D1 cells by fol- 
lowing the superinduction protocol of Mizel and 
Mizel (1981). Briefly, 2 x 10 6 adherent P388D1 
cells were cultured in medium containing 10 ffg/ml 
phorbol myristate acetate and 10 ffg/ml cyclo- 
heximide for 4 h. This medium was replaced by 
fresh medium containing 10 /.tg/ml actinomycin 
D. After 1 h, the cells were washed three times 
and were cultured overnight in fresh medium. 
Cell-free supernatant was collected and protein 
was precipitated with ammonium sulfate (65% 
saturation). After extensive dialysis the sample 
was applied to a Sephadex G-100 column. IL-I 
activity eluted in one peak with a molecular weight 
around 15000. The active fractions were pooled, 
dialyzed, sterilized by filtration and stored at 
-20°C.  
Other lymphokines 
Recombinant murine (mrIL-1) and human 
(hurIL-1) IL- la were generously provided by J.J. 
Farrar, Hoffman La Roche, Nutley, U.S.A. Highly 
purified human recombinant IL-2 (hurIL-2) from 
E. coli (Rosenberg et al., 1984; Wang et al., 1984) 
was a gift from Cetus Corporation, Emeryville, 
CA. Activity in U /ml  for rlL-1 is given as stated 
by the manufacturer (1.5 x 10 6 U/rag and 1.7 x 
107 U/mg for mrIL-1 and hurIL-1 respectively, 
based on half-maximal stimulation). Activity of 
rIL-2 was calculated based on the NIH standard. 
Interleukin-1 assays 
Single cell suspensions of C3H/HeJ  thymo- 
cytes were cultured in culture medium in flat 
bottom 96-weU plates at densities indicated in the 
paper. The total volume was 0.2 ml containing the 
indicated lymphokines. When the classical co- 
stimulator assay was used, the PHA concentration 
was 1/~g/ml for PHA-P (Sigma) or 50 / tg /ml  for 
PHA-M (Sigma). When IL-2 was used as co- 
stimulator for IL-1, its concentration was as indi- 
cated up to 200 U/ml .  After 2-4  days of culture 
in 5% CO 2 and at 90% relative humidity at 37°C, 
the cultures were pulsed for 4-6 h with 1 #Ci/wel l  
of 3H-TdR. The DNA was then precipitated onto 
glass fiber filters using a cell harvester and the 
radioactivity was measured in a liquid scintillation 
counter. 
Results 
We have previously described a second func- 
tion for IL-1 besides its capacity to induce IL-2 
secretion in T cells. This other function is the 
induction of IL-2 receptor expression in thymic 
cell preparations. This finding offers the possibil- 
ity of a test system for IL-1 which is not depend- 
ent on either the IL-2 concentration of the test 
sample itself or the induction of IL-2 by the IL-1 
of the cell culture. 
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Fig. 1. IL-2 dose-response curves in the presence of different 
concentrations of IL-1. The IL-1 was mrIL-1, IL-2 was hurIL-2. 
106 C3H/HeJ  thymoeytes were cultured for 4 days in the 
presence of 50 U IL-1/ml (O), 1 U IL-1/ml ([]), 0.1 U 
IL-1/ml (O) and no IL-1 (n). IL-2 was titrated into these 
cultures at log 2 dilutions. Before harvest the cultures were 
pulsed for 4 h with 1 #Ci/well of 3H-TdR. The data represent 
the mean of duplicate cultures given as counts per rain (cpm)~ 
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Fig. 2. IL-1 dose-response curves in the presence of different 
concentrations of IL-2. The IL-1 was mrIL-1, IL-2 was hurIL-2. 
106 C3H/HeJ  thymocytes were cultured for 4 days in the 
presence of 200 U/ml  IL-2 (O), 50 U /ml  IL-2 (D), 10 U/rnl  
IL-2 (O) and no IL-2 (i). IL-1 was titrated into these cultures 
at log 3 dilutions. Before harvest he cultures were pulsed for 4 
h with 1/.tCi/well of 3H-TdR. The data represent the mean of 
duplicate cultures given as clam. 
In order to have an IL-1 assay system which is 
independent of endogenous IL-2 it was necessary 
to define saturating concentrations of IL-2. IL-2 
produced by thymocytes after IL-1 activation has 
no additional effect on proliferation in cultures 
saturated with IL-2. For that reason thymocytes 
were stimulated by a variety of concentrations of
IL-1, and IL-2 was triated into these cultures. As 
shown in Fig. 1, a concentration of 10 U /ml  of 
recombinant IL-2 was already sufficient to reach 
the plateau levels of proliferation. A further in- 
crease in IL-2 concentration did not increase pro- 
liferation. It was also evident hat different plateau 
levels were reached with different concentrations 
of IL- l .Therefore, the level of proliferation in the 
presence of excess amounts of IL-2 was only de- 
pendent on the concentration of IL-1. To test this 
finding, IL-1 was titrated in the presence of differ- 
ent concentrations of IL-2. As seen in Fig. 2 the 
dose-response curves of recombinant IL-1 in the 
presence of more than 10 U /ml  of recombinant 
IL-2 were practically identical. 
Effect of thymus cell concentration and time of 
incubation on the assay system 
In order to test whether cell density plays a role 
in our assay IL-1 was titrated at different cell 
180000 
concentrations. It was found that the IL-1 con- 
centration at which half-maximal proliferation was 
measured in the presence of 50 U /ml  of hurlL-2 
was not significantly different between 3.8 x 10 4 
and 6 X l0 s cells/ well. Kinetic studies were per- 
formed to determine the optimal time of incuba- 
tion for testing 3H-TdR incorporation. IL-1 titra- 
tions were set up in the presence of saturating 
amounts of IL-2 (50 U /ml )  in replicate cultures. 
Replicates were pulsed with 3H-TdR and harvested 
on days 2, 3 and 4 of culture. Maximal prolifera- 
tion was reached on day 3, but the assay could be 
read as early as day 2. However, the best stimula- 
tion index was obtained on day 4. It is important 
to note again that the IL-1 concentrations which 
induced half-maximal proliferation were not sig- 
nificantly different on the different days of harvest 
(data not shown). 
Comparison of assay sensitivity with the classical 
co-stimulator assay using PHA as costimulator 
Parallel titrations of IL-1 in the presence of 
either 50 U /ml  of IL-2 or 50 #g/ml  of PHA-M 
were performed in order to compare the sensitivity 
of our assay system for IL-1 with the conventional 
co-stimulator assay using suboptimal concentra- 
tions of PHA. The cultures were tested on day 3 
for 3H-TdR incorporation. The titers of IL-1 ob- 
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Fig. 3. Comparison of the PHA and IL-2 co-stimulator assay. 
C3H/He J  thymocytes (4x105/wel l)  were incubated in the 
presence of either hurlL-2 (50 U /ml )  (O) or PHA-M (50 
tLg/ml) (D). mrlL-1 was titrated into these cultures in three-fold 
dilutions. The cells were incubated for 3 days. 4 h prior to 
harvest cells were pulsed with 1 ~Ci/well  of 3H-TdR. The data 
represent the mean of duplicate cultures given as cpm. 
tained in the two systems were identical (Fig. 3). 
This was true for more than 90% of the assays 
performed. In some experiments our assay was up 
to 15-fold more sensitive than the classical 
thymocyte co-stimulator assay. This might be ex- 
plained by the fact that the PHA co-stimulator 
assay is performed using suboptimal concentra- 
tions of mitogen and that the thymic cells due to 
their heterogeneity react differently to these con- 
centrations. Therefore, we concluded that the 
sensitivity of the two assays was comparable and 
that the co-stimulator assay using saturating con- 
centrations of IL-2 was more reproducible. In 
addition, the stimulation index was usually higher 
in the new assay system. IL-2 titrations in both 
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Fig. 4. Titration of different IL-1 molecules. C3H/He J  
thymocytes (5x l05/wel l )  were cultured for 3 days in the 
presence of 50 U /ml  of hurlL-2. Different IL-1 samples were 
added to the cultures in three-fold dilutions. 4 h prior to 
harvest 1 ffCi/well of 3H-TdR was added to each well. The 
data represent the mean of duplicate cultures given as cpm. A: 
(0 )  purified hulL-lf l ;  (D) partially purified natural rolL-l; (e) 
purified hurIL- la.  B: (0 )  purified huIL-lfl; (D) purified 
mrIL-1. 
assay systems were also compared after different 
times of incubation and at various cell densities. 
The assay sensitivity did not differ significantly 
under any of the conditions studied (data not 
shown). 
Effect of different species of IL-1 in the new assay 
system 
Different IL-1 molecules were compared to ob- 
tain information about the general value of the 
test system. Purified recombinant human IL-la, 
purified natural human IL-lfl, recombinant mouse 
IL-1, and semi-purified natural mouse IL-1 from 
the P388D1 macrophage-like c ll line were titrated 
under the conditions given in the legend to Fig. 
4A and B. It is clear from the figure that these 
different IL-1 molecules gave a positive signal in 
this test system. Also, the titration curves were 
superimposable and reached the same plateau, 
suggesting that the mechanisms of activation were 
similar for all IL-1 samples. 
Discussion 
A variety of assay systems is available to detect 
and quantitate IL-1. They are all based on the 
ability of IL-1 to induce IL-2 production in T cells 
or thymomas. All test systems are of similar sensi- 
tivity except he 'conversion assay' which seems to 
be the most sensitive (Conlon, 1983). In all sys- 
tems the proliferation due to IL-2 is quantitated. 
Because of IL-2 contamination it has been impos- 
sible to determine IL-1 and IL-l-like activities in 
supernatants of cell populations containing cells 
of the T cell lineage. Only in exceptional cases of 
T cell supernatants which were devoid of IL-2 
could IL-1 activity be measured. We needed an 
assay system for IL-1 which was not influenced by 
IL-2. The assay which was developed was based 
on our previous finding (M~innel et al., 1985) that 
IL-1 induces IL-2 receptor expression on murine 
thymocytes in the presence of IL-2 which results 
in proliferation. Using thymocytes in the presence 
of saturating amounts of IL-2 the proliferation 
induced was directly dependent on the IL-1 con- 
centration and reached plateau levels which were 
dependent on the concentration of IL-1. The assay 
was highly reproducible and yielded titration 
curves with high stimulation indices. 
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The titers of IL-1 were independent of cell 
numbers over a range of at least one log10 and 
could be read as early as day 2 of culture. A 
longer culture period resulted in higher 3H-TdR 
incorporation and better stimulation indices but 
determination of the titer of IL-1 was the same. 
Sensitivity fluctuations as seen using suboptimal 
amounts of mitogen in combination with thymoma 
cells have not been observed in many experiments. 
When bacterial lipopolysaccharide (LPS) is ex- 
cluded from the cultures, the requirement for 
thymocytes from the C3H/HeJ  LPS low re- 
sponder strain is not stringent. IL-1 could be 
measured in the same culture wells in which the 
assay was set up and transfer of supernatants was 
therefore not required. This eliminated an ad- 
ditional putative source of experimental error. 
Moreover, any source of IL-2 which is free of 
mitogen or IL-l-like activities can be used as 
growth factor. For these reasons the described 
assay is very simple, reliable and does not require 
long-term culture and recloning of unstable IL-1- 
sensitive cell lines for assay. On the other hand, 
one has to keep in mind that all IL-l-like activities 
will give a positive signal in this assay. One of 
these activities is T cell cytotoxicity-inducing fac- 
tor 1 (TCF1) which like IL-1 induces proliferation 
of thymocytes (Falk et al., 1985). TCF1, however, 
is different from IL-1 with respect to cellular 
source and biochemical data. Another factor that 
was shown to stimulate IL-2-dependent cells is B 
cell-stimulating factor 1 (BSF-1), now termed in- 
terleukin-4 (Fernandez-Botran et al., 1986). This 
factor was also active in our IL-1 assay (data not 
shown). One also has to be aware of the fact that 
the concentration of T cell mitogens must be 
rigorously controlled in the cultures, but this is 
true for all assays for IL-1. 
In conclusion, our new assay for IL-1 is supe- 
rior to other IL-1 assays in that it can measure 
IL-1 independent of IL-2 production. Thus, IL-1 
titers in IL-2-containing supernatants can be de- 
termined. 
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